Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(3.65)
# 707
Out of 5,182 analysts
76
Total ratings
51.35%
Success rate
41.06%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AURA Aura Biosciences | Assumes: Buy | $22 | $6.54 | +236.39% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $2.63 | +280.23% | 1 | May 15, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $10.17 | +293.31% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.01 | +890.10% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $17.81 | -66.31% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $4.93 | +163.69% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $20 | $23.78 | -15.90% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $5.11 | +350.10% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $67.48 | +11.14% | 13 | Apr 28, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $36 | $21.45 | +67.83% | 14 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.01 | +1,385.15% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $6.69 | +273.69% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $50.01 | -0.02% | 13 | Nov 26, 2024 |
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $6.54
Upside: +236.39%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $2.63
Upside: +280.23%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $10.17
Upside: +293.31%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.01
Upside: +890.10%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $17.81
Upside: -66.31%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $4.93
Upside: +163.69%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $20
Current: $23.78
Upside: -15.90%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $5.11
Upside: +350.10%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $67.48
Upside: +11.14%
Day One Biopharmaceuticals
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $21.45
Upside: +67.83%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.01
Upside: +1,385.15%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $6.69
Upside: +273.69%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $50.01
Upside: -0.02%